# [Corrigendum] CDKN2A (p16INK4A) affects the anti-tumor effect of CDK inhibitor in somatotroph adenomas

**Authors:** Yiyuan Chen, Zhenye Li, Qiuyue Fang, Hongyun Wang, Chuzhong Li, Hua Gao, Yazhuo Zhang

PMC · DOI: 10.3892/ijmm.2026.5732 · International Journal of Molecular Medicine · 2026-01-14

## Full-text entities

- **Genes:** Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, Cdk4 (cyclin-dependent kinase 4) [NCBI Gene 94201], Egfr (epidermal growth factor receptor) [NCBI Gene 24329] {aka ERBB1, ErbB-1, Errp}, Cdh2 (cadherin 2) [NCBI Gene 83501] {aka N-cadherin}, Cdkn2a (cyclin-dependent kinase inhibitor 2A) [NCBI Gene 25163] {aka Arf, INK4A, MTS1, p16, p16Cdkn2a, p19ARF}
- **Diseases:** tumor (MESH:D009369), somatotroph adenomas (MESH:D049912)
- **Chemicals:** Palbociclib (MESH:C500026)
- **Cell lines:** GT1-1 — Mus musculus (Mouse), Transformed cell line (CVCL_6236), GH3 — Rattus norvegicus (Rat), Rat pituitary gland neoplasm, Cancer cell line (CVCL_0273)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12834368/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12834368/full.md

---
Source: https://tomesphere.com/paper/PMC12834368